These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment for community acquired pneumonia: more support for doxycycline. Ditmanson L, Apgar D. Arch Intern Med; ; 159(15):1814-5. PubMed ID: 10448791 [No Abstract] [Full Text] [Related]
4. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Teh B, Grayson ML, Johnson PD, Charles PG. Clin Microbiol Infect; 2012 Apr; 18(4):E71-3. PubMed ID: 22284533 [Abstract] [Full Text] [Related]
9. [Epidemiology and Aetiology of Community-acquired Pneumonia (CAP)]. Pletz MW, Rohde G, Schütte H, Bals R, von Baum H, Welte T, CAPNETZ-Studiengruppe. Dtsch Med Wochenschr; 2011 Apr; 136(15):775-80. PubMed ID: 21469047 [Abstract] [Full Text] [Related]
10. Quinolones as an alternative treatment of chlamydial, mycoplasma and gonococcal urogenital infections. Ziegler C, Stary A, Mailer H, Kopp W, Gebhart W, Söltz-Szöts J. Dermatology; 1992 Apr; 185(2):128-31. PubMed ID: 1421625 [Abstract] [Full Text] [Related]
19. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections. Drehobl M, Koenig L, Barker M, St Clair P, Maladorno D. Chemotherapy; 1997 Aug; 43(5):378-84. PubMed ID: 9309373 [Abstract] [Full Text] [Related]
20. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, Leinonen M, Saikku P, Myint S. Thorax; 2001 Feb; 56(2):109-14. PubMed ID: 11209098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]